Wen X#, Zeng X#, Shi C, Liu J, Zhang Y, Shi M, Li J, Chen H, Zhuang R, Chen X*, Zhang X*, Guo Z*. Optimum combination of radiopharmaceuticals-basedtargeting-triggering-therapy effect and PD-L1 blockade immunotherapy. AdvancedTherapeutics, 2023, 6.
2024.04.22